Basel Medical Group Outperforms SeaStar Medical in Financial Analysis

Comparison of two small-cap medical companies shows Basel Medical Group has stronger profitability and earnings.

Apr. 17, 2026 at 10:20pm

Got story updates? Submit your updates here. ›

A cinematic close-up of heavy, metallic banking and financial machinery, representing the institutional power and complex infrastructure of the medical industry without using literal currency or charts.An extreme close-up of the inner workings of the medical finance industry reveals the complex machinery powering the sector's institutional wealth and influence.Denver Today

A financial analysis comparing Basel Medical Group (NASDAQ:BMGL) and SeaStar Medical (NASDAQ:ICU), two small-cap medical companies, reveals that Basel Medical Group outperforms SeaStar Medical across several key metrics, including higher revenue, earnings, and profitability.

Why it matters

This analysis provides investors with valuable insights into the relative financial health and growth potential of these two medical companies, which could inform investment decisions in the small-cap healthcare sector.

The details

The analysis shows that Basel Medical Group has higher net margins, return on equity, and return on assets compared to SeaStar Medical. Basel Medical Group also has higher revenue and earnings per share. Additionally, Basel Medical Group's stock is less volatile than the overall market, while SeaStar Medical's stock is more volatile.

  • The financial data and analysis is current as of April 17, 2026.

The players

Basel Medical Group

An investment holding company that provides orthopedic surgeries, medical care, and diagnostic services, headquartered in Singapore.

SeaStar Medical

A medical device company developing a platform therapy to reduce the consequences of hyperinflammation, headquartered in Denver, Colorado.

Got photos? Submit your photos here. ›

What they’re saying

“This analysis provides investors with valuable insights into the relative financial health and growth potential of these two medical companies, which could inform investment decisions in the small-cap healthcare sector.”

— Linda Flegge, Author

The takeaway

The financial analysis highlights Basel Medical Group's stronger profitability, earnings, and lower volatility compared to SeaStar Medical, making it a potentially more attractive investment option for investors in the small-cap medical sector.